醒痴方加针刺对老年性痴呆患者MMSE、Hcy、EEG的影响
|
摘要
目的:
老年性痴呆症(阿尔茨海默病,Alzheimer′s disease,AD)是1907年AloisAlzheimer首先发现并命名的一种神经系统退行性疾病。随着世界人口的老龄化,AD的发病率呈不断上升趋势,目前该病列死亡原因第4位(仅次于心脏病、肿瘤和中风),成为当前老年医学所面临的最为严峻的问题之一。
导师刘友章教授擅长治疗老年病,在长期韵临床实践中认为AD患者都不同程度地在肾虚的基础上兼有脾虚的表现。因此,针对AD患者脾肾虚衰、气血阴阳亏损、脑失所养、痰瘀蒙蔽清窍这一病理环节,刘友章教授立补益脾肾、化痰祛瘀的治疗方法和经验方—醒痴方,结合针刺百会、四神聪、神门、足三里等穴位进行早期治疗,显示出较好的临床效果。故本研究在使用常规西药治疗的基础上,加用醒痴方并结合针刺治疗脾肾两虚、痰浊阻窍型轻-中度AD患者20例,并与单纯中医、单纯西医治疗组各20例随机对照,以进一步探讨醒痴方加针刺在脾肾两虚、痰浊阻窍型轻-中度AD治疗中的疗效。
方法:
研究包括文献研究和临床研究。文献研究中,从西医对AD病因及发病机制的认识、与AD有关的血液生化标记物、AD的神经影像学和电生理改变及传统中医对AD的论述、AD的中药及针灸治疗进展、中医药治疗AD的优势等方面进行了详细的整理和总结。临床研究中,临床观察60例脾肾两虚、痰浊阻窍型轻-中度AD患者,采用随机对照方法将患者分成三组,单纯中医组、单纯西医组及中西医结合组各20例。单纯中医组给予醒痴方加针刺治疗;单纯西医组口服安理申、都可喜、脑复康片治疗;中西医结合组口服西药、醒痴方并行针刺治疗,三组的疗程均为4周。
结果:
经治疗4周后,口服西药、醒痴方并行针刺的中西医结合组的中医总疗效、对MMSE量表积分的改善、对AD患者的检测指标(血浆Hcy、脑电图)的改善均优于单纯中医及单纯西医组(P＜0.05)。
结论:
在常规西药治疗的基础上,醒痴方加针刺的中西医结合方案对脾肾两虚、痰浊阻窍型轻-中度AD患者疗效确切,临床试验中未发现该方案有不良反应,可考虑作为AD患者的常规治疗方案。
Objective:
Alzheimer' s disease is one of the degenerative disease of nervous system found firstly and nominated by Alois Alzheimer in 1907.With the aging of world population,the incidence rat-e of AD.shows rising constantly tendency,Now AD list 4th of cause of death(second only heart disease,tumor and apoplexy),become one of the most severe questions of geriatric medicine faced with.
My tutor Prof.Liu Youzhang is good at the treatment of senile disease, thinking that AD patients have kidney and spleen asthenia to different degree. So aiming at the pathological element of spleen and kidney asthenia,weakness of Qi,blood,Yin and Yang,brain loss the nourishment,phlegm and blood stasis blocking the upper orifices of AD patients,Prof.Liu Youzhang created treatment method of tonifying spleen and renal,dissipating phlegm and removing blood stasis and empirical formula xingchi Decoction combined,with acupuncture Baihui,Sishencong,Shenting etc acupoint for early treatment, displayed better clinical effects.So in this research,we adopted xingchi Decoction combined with acupuncture to treat 20 slight of midrange AD patients of both the spleen and kidney asthenia,phlegm and blood stasis blocking clear orifices on the basis of routine western medicine,and randomized control with 20 simple traditional Chinese medicine group,20 simple western medicine group, so as to further approaching the effects and possible mechanism of xingchi Decoction combined with acupuncture in treating AD of both the spleen and kidney asthenia,phlegm and blood stasis blocking clear orifices.
Methods:
The research consists of two parts:literature review and clinical research.In literature review,we made systematic summary on recognition of etiology and pathogenesis of AD ofmodern medicine,blood biochemical marker related to AD,neuroimaging and electrophysiological change of AD,the discuss of traditional Chinese medicine on AD,traditional Chinese medicine and acupuncture therapy progress and the advantages of traditional Chinese medicine therapy etc.In clinical research,we made clinical observation of 60 slight of midrange AD patients of both the spleen and.kidney asthenia,phlegm and blood stasis blocking clear orifices,60 AD patients were randomly divided into 3 groups:20 simple traditional Chinese medicine group,20 simple western medicine group and 20 combination of traditional Chinese medicine and western medicine group.We adopted xingchi Decoctioncombined with acupuncture to treat AD in simple traditional Chinese medicine group;adopted aricep、duxil、pisacetam tablets for oral administration in simple western medicine group and western medicine combined with xingchi Decoction and acupuncture in combination of traditional Chinese medicine and western medicine group,3 groups' course of treatment were 4 weeks.
Results:
After 4 weeks treatment,traditional Chinese medicine therapeutic effects, improvement of measuring scale score of mini-mental state examination and detection index of AD patients(blood plasma homocysteine,EEG)were all better in combination of traditional Chinese medicine and western medicine group compared with simple traditional Chinese medicine group and simple western medicine group(P＜0.05).
Conclusion:
On the basis of routine western medicine,the effects of combination of traditional Chinese medicine and western medicine of xingchi Decoction combined with acupuncture were definite in treating slight of midrange AD patients of both the spleen and kidney asthenia,phlegm and blood stasis blocking clear orifices.There were no adverse effects in clinical research. and it can be used as conventional therapy plan for AD patients.
老年性痴呆症(阿尔茨海默病,Alzheimer′s disease,AD)是1907年AloisAlzheimer首先发现并命名的一种神经系统退行性疾病。随着世界人口的老龄化,AD的发病率呈不断上升趋势,目前该病列死亡原因第4位(仅次于心脏病、肿瘤和中风),成为当前老年医学所面临的最为严峻的问题之一。
导师刘友章教授擅长治疗老年病,在长期韵临床实践中认为AD患者都不同程度地在肾虚的基础上兼有脾虚的表现。因此,针对AD患者脾肾虚衰、气血阴阳亏损、脑失所养、痰瘀蒙蔽清窍这一病理环节,刘友章教授立补益脾肾、化痰祛瘀的治疗方法和经验方—醒痴方,结合针刺百会、四神聪、神门、足三里等穴位进行早期治疗,显示出较好的临床效果。故本研究在使用常规西药治疗的基础上,加用醒痴方并结合针刺治疗脾肾两虚、痰浊阻窍型轻-中度AD患者20例,并与单纯中医、单纯西医治疗组各20例随机对照,以进一步探讨醒痴方加针刺在脾肾两虚、痰浊阻窍型轻-中度AD治疗中的疗效。
方法:
研究包括文献研究和临床研究。文献研究中,从西医对AD病因及发病机制的认识、与AD有关的血液生化标记物、AD的神经影像学和电生理改变及传统中医对AD的论述、AD的中药及针灸治疗进展、中医药治疗AD的优势等方面进行了详细的整理和总结。临床研究中,临床观察60例脾肾两虚、痰浊阻窍型轻-中度AD患者,采用随机对照方法将患者分成三组,单纯中医组、单纯西医组及中西医结合组各20例。单纯中医组给予醒痴方加针刺治疗;单纯西医组口服安理申、都可喜、脑复康片治疗;中西医结合组口服西药、醒痴方并行针刺治疗,三组的疗程均为4周。
结果:
经治疗4周后,口服西药、醒痴方并行针刺的中西医结合组的中医总疗效、对MMSE量表积分的改善、对AD患者的检测指标(血浆Hcy、脑电图)的改善均优于单纯中医及单纯西医组(P＜0.05)。
结论:
在常规西药治疗的基础上,醒痴方加针刺的中西医结合方案对脾肾两虚、痰浊阻窍型轻-中度AD患者疗效确切,临床试验中未发现该方案有不良反应,可考虑作为AD患者的常规治疗方案。
Objective:
Alzheimer' s disease is one of the degenerative disease of nervous system found firstly and nominated by Alois Alzheimer in 1907.With the aging of world population,the incidence rat-e of AD.shows rising constantly tendency,Now AD list 4th of cause of death(second only heart disease,tumor and apoplexy),become one of the most severe questions of geriatric medicine faced with.
My tutor Prof.Liu Youzhang is good at the treatment of senile disease, thinking that AD patients have kidney and spleen asthenia to different degree. So aiming at the pathological element of spleen and kidney asthenia,weakness of Qi,blood,Yin and Yang,brain loss the nourishment,phlegm and blood stasis blocking the upper orifices of AD patients,Prof.Liu Youzhang created treatment method of tonifying spleen and renal,dissipating phlegm and removing blood stasis and empirical formula xingchi Decoction combined,with acupuncture Baihui,Sishencong,Shenting etc acupoint for early treatment, displayed better clinical effects.So in this research,we adopted xingchi Decoction combined with acupuncture to treat 20 slight of midrange AD patients of both the spleen and kidney asthenia,phlegm and blood stasis blocking clear orifices on the basis of routine western medicine,and randomized control with 20 simple traditional Chinese medicine group,20 simple western medicine group, so as to further approaching the effects and possible mechanism of xingchi Decoction combined with acupuncture in treating AD of both the spleen and kidney asthenia,phlegm and blood stasis blocking clear orifices.
Methods:
The research consists of two parts:literature review and clinical research.In literature review,we made systematic summary on recognition of etiology and pathogenesis of AD ofmodern medicine,blood biochemical marker related to AD,neuroimaging and electrophysiological change of AD,the discuss of traditional Chinese medicine on AD,traditional Chinese medicine and acupuncture therapy progress and the advantages of traditional Chinese medicine therapy etc.In clinical research,we made clinical observation of 60 slight of midrange AD patients of both the spleen and.kidney asthenia,phlegm and blood stasis blocking clear orifices,60 AD patients were randomly divided into 3 groups:20 simple traditional Chinese medicine group,20 simple western medicine group and 20 combination of traditional Chinese medicine and western medicine group.We adopted xingchi Decoctioncombined with acupuncture to treat AD in simple traditional Chinese medicine group;adopted aricep、duxil、pisacetam tablets for oral administration in simple western medicine group and western medicine combined with xingchi Decoction and acupuncture in combination of traditional Chinese medicine and western medicine group,3 groups' course of treatment were 4 weeks.
Results:
After 4 weeks treatment,traditional Chinese medicine therapeutic effects, improvement of measuring scale score of mini-mental state examination and detection index of AD patients(blood plasma homocysteine,EEG)were all better in combination of traditional Chinese medicine and western medicine group compared with simple traditional Chinese medicine group and simple western medicine group(P＜0.05).
Conclusion:
On the basis of routine western medicine,the effects of combination of traditional Chinese medicine and western medicine of xingchi Decoction combined with acupuncture were definite in treating slight of midrange AD patients of both the spleen and kidney asthenia,phlegm and blood stasis blocking clear orifices.There were no adverse effects in clinical research. and it can be used as conventional therapy plan for AD patients.
引文
[1]王维治(主编).神经病学(第5版教材),北京:人民卫生出版社,2007:266-272.
[2]张明圆,瞿光亚,王征宇,等.痴呆和Alzheimer病的患病率研究[J].中华医学杂志,1990:70(8):424.
[3]王德全,姜晓丹.老年痴呆患病率及危险因素的调查[J].中国公共卫生杂志,2002:18(12):1948.
[4]江三多,冯国鄞,吴晓东.Ahheimer病与载脂蛋白Eε4等位基因的关联分析[J].中华精神科杂志,1996;29(1):15.
[5]崔天盆,周新,徐红,等.载脂蛋白E基因多态性与散发性老年性痴呆病的关系[J].中国病理生理杂志,2000;16(8):741.
[6]毕胜,王德生,张昱,等.低密度脂蛋白受体相关蛋白基因3号外显子多态性与阿尔茨海默病的相关性研究[J].中国神经精神疾病杂志,2000;26(3):167.
[7]李求兵,梅荣.老年痴呆症的中西医诊断与治疗[J].北京:中国医药科技出版社,1999.
[8]胡昔权,钱采韵,窦祖林,等.Alzheimer病与老年脑中β淀粉样蛋白免疫组化的研究[J].中国神经精神疾病杂志,1998;24(1):6.
[9]马秋兰,钱采韵,刘焯霖,等.阿尔茨海默病患者早老素1基因5号外显子新突变点的研究[J].中国神经精神疾病杂志,1999;25(3):142.
[10]Edelbem HK,et al.The biology of Alzheimer's disease[J].Mechanisms of·Ageing and Development,1996:91:95.
[11]杜泽英,李晓玉.阿尔采末病与免疫炎症反应的相关性[J].生理科学进展,1998;29(3):253.
[12]Me Geerpt.神经退行性变的免疫学机制[J].国外医学·药学分册,1997;24(2):94-97.
[13]杜泽英,李晓玉.阿尔采末病与免疫炎症反应的相关性[J].生理科学进展,1998;29(3):253.
[14]马春,王爱民.脑的老化与痴呆[M].北京:北京医科大学与中国协和医科大学联合出版社,1995:76.
[15]陈明,李爱媛.Alzheimer病与神经元钙稳态[J].生命的化学,1997;17(3):46-49.
[16]秦斌,王新德.β淀粉样蛋白及Tau蛋白和Alzheimer病关系的研究[J]。国外医学·老年医学分册,1995;16(6):267.
[17]Yu ZE,Cheng GI,Hu BR.Mechamism of coloic impairment on learning and memory and protective effect of CGP36742 in mice[J].Brain Rec,1997:750(1):53-59.
[18]盛树力,裴进京.老年性痴呆的临床和分子学基础[J],北京:科学技术文献出版社,1998.
[19]黄诚.Alzheimer病脑内发现第三种病理损害[J].生理科学进展,1998;29(1):34.
[20]李卫平,姚志彬,陈以慈,等.老年期痴呆患者脑海马区胆碱能纤维分布与临床病理研究[J].中华神经精神科杂志,1995;28(2):76.
[21]江岩,孙成文译.大脑胆碱能神经系统的老化及其防治[J].国外医学·老年医学分册,1995;16(6):270.
[22]Ling Y,Morgan K,Kalsheker N.Amyloid precursor protein(APP)and the biology of proteolytic processing:releveance to Alzheimer's disease[J].Int J Biochem Cell Biol,2003;35(II):1505.
[23]PADovani A,Pastorino L,Borroni B,et al.Amyloid precursor protein in platelets:a peripheral marker for the diagnosis of sporADic AD[J].Neurolo,2001;57(12):2243.
[24]Baskin F,Rosenberg RN,Fang X,et al.Correlation of statin-increased platelet APP ratios and reduced blood lipids in AD patients[J].Neurology,2003;60(12):60.
[25]Assini A,Cammarata S,Vitali A,et al.Plasma levels of amyloid [beta]-protein42 are increased in women with mild cognitive impairment[J].Neurology,2004;63(5):828.
[26]Zoe A,John AL,Linda HY,et al.Serum creatinine level correlate with plasma amyloid β protein[J].Alzheimer Disease Associated Disorders,2002;16(2):187.
[27]MichaelL.Increased homocysteine and decreased ADenosine formation in Alzheimer's disease[J].Neurol Res,2004;26(5):554.
[28]Hull M,Pasinetti GM,Aisen PS.Elevated plasma neopterin levels in Alzheimer disease[J].Alzheimer Disease Associated Disorders,2000:14(4):228.
[29]Schipper H,Chertkow H,Mehindate K,et al.Evaluation of heme oxygenase-1as a systemic biological marker of sporADic AD[J].Neurology,2000;54(6):1297.
[30]Gattaz WF,Forlenza or,Talib LL,et al.Platelet phospholipase A(2) activity in Alzheimer' s disease and mild cognitive impairment[J].J Neural Transmission,2004;111(5):591.
[31]Lorenzl S,Albers DS,Relkin N,et al.Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer' s disease[J].Neurochem Int,2003:43(3):191.
[32]马路,张吉强,姚清.雌激素合成酶与雌激素受体在神经干细胞及其分化后细胞内的表达[J].重庆医学,2005;34(4):560.
[33]Zhang S,Huang Y,Zhu YC,et al.Estrogen stimulates release of secreted amyloid precursor protein from primary rat cortical neurons via protein kinase C pathway[J].Acta Pharmacol Sin,2005;26(2):171.
[34]Rainer T,Dip 1P,Dirk A.Serum nerve growth factor concentration and its role in the preclinical stage of dementia[J].Am J Psychiatyy,2002;159(7):1227.
[35]Grammas P,Ovase R.Cerebrovascular transforming growth factor-betac ontributes to inflammation in th Alzheimer' s disease brain[J].Am J Pathol,2002:160(5):1583.
[36]秦新月,余刚,董维伟,等.TNF2A对离体培养的少突胶质细胞和髓鞘生长的影响[J].重庆医学,2004;33(7):1061.
[37]Molina M,Robert AF,Krnneth H.Oxidative stress and neuroinflammation in Alzheimer' s diseaseand amyotrophiclateral sclerosis:common links and potential therapentic targets[J].J Alzheimer' s Dis,2004;6(2):147.
[38]Quintanilla RA,Orellana DI,Gonzalez-Billault C,et al.Interleukin-6induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p3 5pathway[J].Exp Cel IRes,2004;295(1):245.
[39]Bagli M,Papassotiropoulos A,Hampel H.Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer' s disease Results of a pilot study[J].Eur Arc Psychiatry Clin Neurosci,2003;253(1):44.
[40]董会卿,颜振瀛,李坤成,等.MRI线性测量局部脑萎缩对早期阿尔兹海默病的诊断意义.中华神经科杂志,1998;31:92-94.
[41]Knopman DS,DeKosky ST,Cummings JL,et al.Practice parameter:Diagnosis of dementia(an evidence-based review)Report of the Qualit Standards Subcommittee of the American AcADemy of Neurology.Neurology,2001; 56:1143-1153.
[42]Villareal DT,Morris JC.The Diagnosis of Alzheimer' s Disease.Alzheimer' s Disease Review,1998:3:142-152.
[43]Anthony D,Wagner AD.Early detection of Alzheimer' s disease:An MRI marker for people at risk.Nature Neuroscience,2000:3:973-974.
[44]Herholz K.PET studies in dementia.Ann Nucl Med,2003:17:79-89.
[45]李岳峙,王明时.脑电在老年性痴呆诊断中的应用.国外医学生物医学工程分册,1998:21(1):8-11.
[46]Goodin D,Squires K,Starr A.A long latency event-related components of the auditory evoked potential in dementia.Brain,1978;101:635-648.
[47]Goodin D,Starr A,Chippendale T,et al.Sequential changes in the P300component of the auditory evoked potential in confusional states and dementing illness.Neurology,1983;33:1215-1218.
[48]Michikawa M.The role of cholesterol in pathogenesis ofAlzheimer' s disease dual me tabolic in te raction between amyloid betal protein and cholescrol[J].Mol Neurobiol,2003;27(1):1-12.
[49]Caballero,J NabataM.Do statins slow down Alzheimer' s diseases[J].Clin Pharm Ther,2004;29(3):209-213.
[50]Mackenzie IR,Moons DG.Nonsteroid anti-inflam matory drug use and Alzheimer type pathology in aging[J].Neurology,2002:16(1):39-41.
[51]Jay PR,Loren GI.Focus on Donepezil A reverstale acctyleholineste rase inbibitor for the neament of Alzheimers' s disease[J].Medical Progress SEA,2003:25(1):42.
[52]张振馨,赵洁皓,黄觉斌,等.老年性痴呆(AD)的药物治疗[M].北京:科学技术文献出版社,2000,54-80.
[53]Poirier J,Delisle MC,Quirion R,et al.Apolipoprote in E4 allele as a predictor of cholinergic deficits and treatment outeomc in Alzheimer' s diease[J],Proc Natl AcAD Sci USA,2002:92(2):260-284.
[54]Cummings JI,Cyrus PA,Bieber E,et al.Metrifonate treatment of the cognitive defic of Alzheiners' s disease[J].Neurology,2002;50(10):1214-1221.
[55]花戎.增智灵对老年痴呆长谷川量表与实验鼠的影响.辽宁中医杂志,2003;30(6):510.
[56]周荣根.白虎汤加减治疗老年性痴呆23例.陕西中医,2003;23(8):700.
[57]康雁,易志宏,王丽.自拟扶智汤治疗老年痴呆症23例疗效观察.中医药学报, 2000:(2):10.
[58]黄冬度.中药治疗老年痴呆49例.实用中医药杂志,2003;19(9):465.
[59]李琼锋,郭翔兵.七生力片治疗老年性痴呆30例.福建中医药,2003;34(1):14.
[60]王娅玲.辨证治疗老年性痴呆22例小结.浙江中西医结合杂志,2000;10(6):349.
[61]王建明.七福饮加味治疗老年性痴呆32例.辽宁中医杂志,2002;29(1):43.
[62]卢绍城.老年性痴呆诊治心法.辽宁中医学院学报,2002;4(1):8.
[63]杨湘潭.针灸醒脑开窍法为主治疗老年性痴呆26例[J].中国针灸,1996;16,(11):3.
[64]唐勇,余曙光,蓝群.针刺对老年痴呆认知功能及自由基的影响.安徽中医临床杂志,2000;12(6):508-509.
[65]唐勇,余曙光,陈瑾.针刺对老年性痴呆认知功能及AchE的影响.上海针灸杂志,2001:20(3):6-7.
[66]杨子江,李淑娥.多针透刺法治疗老年性痴呆.针灸临床杂志,1995;11(3):34.
[67]沈卫东.老年痴呆针灸治疗的临床初步研究.上海针灸杂志,1996;15(5):5.
[68]叶衡.四神聪对锋刺治疗老年性痴呆.上海针灸杂志,1993;12(11):520.
[69]赖新生,余瑾,庄礼兴.针刺治疗老年性血管性痴呆的疗效观察.中国针灸,1997:17(4):201.
[70]贺丹,李瑞利,李风鸾.脑复活因子穴位注射疗法治疗阿尔茨海默病疗效观察.脑与神经疾病杂志,2000;8(2):109-111.
[71]董俊峰.穴位注射疗法治疗老年性痴呆症86例.上海针灸杂志,1997;16(3):9.
[72]董宇翔,富琦,李晓春.针刺配合脑活素穴位注射治疗老年性痴呆症.中风与神经疾病杂志,1997;14(4):242.
[73]杨树成.水针治疗老年性痴呆症26例.浙江中医杂志,1995;30(8):357.
[74]穆艳云,李忠仁.针药结合治疗阿尔茨海默病临床研究.上海针灸杂志,2001;20(3):3-5.
[75]李小衡,刘本立.针灸结合中药治疗老年性痴呆病60例.湖南中医药导报,1998;4(12):18-19.
[76]梁忠,吴强,胡兰.针刺中药合用治疗老年性痴呆11例的临床总结.中国针灸,1998:18(12):712-714.
[77]欧阳颀,李忠仁,穆艳云,等.电针合并奋乃静治疗阿尔茨海默病精神症状的 临床观察.上海针灸杂志,2000;19(6):16-17.
[78]侯安乐,卜渊.针刺药氧治疗老年期痴呆32例临床研究.中国针灸,2000;20(7):397.
[79]车戬,许益强.针药并举治疗老年痴呆症25例.辽宁中医杂志,1997;24(8):317.
[80]罗玉风,盛艳萍,王伟桥.针药并治老年痴呆30例疗效观察.针灸临床杂志,1995:11(1):15.
[81]孙长旺.针刺四神穴为主治疗老年痴呆症经验.天津中医,1997;14(2):79-80.
[82]韦思泉.针药并用治疗老年性痴呆25例.黑龙江中医药,1999;(3):57.
[83]董洪涛,白英.针刺疗法对老年性痴呆患者MMSE量表得分的影响.中医外治杂志,2002:11(3):6-7.
[84]伦新,杨文辉.“CT定位围针法”治疗痴呆的临床观察.上海针灸杂志,2000;19(1):20.
[85]尚颖,丁宁.针刺治疗老年性痴呆24例TCD观察.中国中医药科技,2003;10(4):229.
[86]姜国华,徐强,张洋.针刺对老年性痴呆神经行为学影响的临床研究.针灸临床杂志,2004;20(4):1-3.
[87]罗玳红,赖新生,唐纯志.电针治疗老年性痴呆大鼠血清β淀粉样蛋白及生长因子水平的影响.中国中医药信息杂志,2003;10:10.
[88]Joosten E,Lesaffre E,Riezler R,et al.Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in early patients with Alzheimer' s disease[J].Gerontol A Biol Sci Med Sci,1997:52:M57-59.
[89]柯晓燕,张颖冬,沈伟,等.老年性痴呆52例血浆同型半胱氨酸水平的研究[J].南京医科大学学报(自然科学版),2002;22(5):386.
[90]李方明,彭海.阿尔茨海默病与维生素B12及同型半胱氨酸的相关性[J].中国临床康复,2004;28(8):6210.
[91]张诚,吴瑞枝,陈芷茹.43例老年性痴呆的临床与分析[J].临床脑电学杂志,1995:4(3):65.
[92]陆小莲,杨红,周谷兰,等.老年性痴呆的脑电图观察.河北医药,2005;11(10):930.
[93]戴新民,张尊祥,等.楮实治疗老年性痴呆的临床观察.解放军保健医学杂志,1999;4:22.
[94]唐省三.“针必取三里,灸必加关元”浅见[J].山东中医杂志,2002;21(4):245-246.
[2]张明圆,瞿光亚,王征宇,等.痴呆和Alzheimer病的患病率研究[J].中华医学杂志,1990:70(8):424.
[3]王德全,姜晓丹.老年痴呆患病率及危险因素的调查[J].中国公共卫生杂志,2002:18(12):1948.
[4]江三多,冯国鄞,吴晓东.Ahheimer病与载脂蛋白Eε4等位基因的关联分析[J].中华精神科杂志,1996;29(1):15.
[5]崔天盆,周新,徐红,等.载脂蛋白E基因多态性与散发性老年性痴呆病的关系[J].中国病理生理杂志,2000;16(8):741.
[6]毕胜,王德生,张昱,等.低密度脂蛋白受体相关蛋白基因3号外显子多态性与阿尔茨海默病的相关性研究[J].中国神经精神疾病杂志,2000;26(3):167.
[7]李求兵,梅荣.老年痴呆症的中西医诊断与治疗[J].北京:中国医药科技出版社,1999.
[8]胡昔权,钱采韵,窦祖林,等.Alzheimer病与老年脑中β淀粉样蛋白免疫组化的研究[J].中国神经精神疾病杂志,1998;24(1):6.
[9]马秋兰,钱采韵,刘焯霖,等.阿尔茨海默病患者早老素1基因5号外显子新突变点的研究[J].中国神经精神疾病杂志,1999;25(3):142.
[10]Edelbem HK,et al.The biology of Alzheimer's disease[J].Mechanisms of·Ageing and Development,1996:91:95.
[11]杜泽英,李晓玉.阿尔采末病与免疫炎症反应的相关性[J].生理科学进展,1998;29(3):253.
[12]Me Geerpt.神经退行性变的免疫学机制[J].国外医学·药学分册,1997;24(2):94-97.
[13]杜泽英,李晓玉.阿尔采末病与免疫炎症反应的相关性[J].生理科学进展,1998;29(3):253.
[14]马春,王爱民.脑的老化与痴呆[M].北京:北京医科大学与中国协和医科大学联合出版社,1995:76.
[15]陈明,李爱媛.Alzheimer病与神经元钙稳态[J].生命的化学,1997;17(3):46-49.
[16]秦斌,王新德.β淀粉样蛋白及Tau蛋白和Alzheimer病关系的研究[J]。国外医学·老年医学分册,1995;16(6):267.
[17]Yu ZE,Cheng GI,Hu BR.Mechamism of coloic impairment on learning and memory and protective effect of CGP36742 in mice[J].Brain Rec,1997:750(1):53-59.
[18]盛树力,裴进京.老年性痴呆的临床和分子学基础[J],北京:科学技术文献出版社,1998.
[19]黄诚.Alzheimer病脑内发现第三种病理损害[J].生理科学进展,1998;29(1):34.
[20]李卫平,姚志彬,陈以慈,等.老年期痴呆患者脑海马区胆碱能纤维分布与临床病理研究[J].中华神经精神科杂志,1995;28(2):76.
[21]江岩,孙成文译.大脑胆碱能神经系统的老化及其防治[J].国外医学·老年医学分册,1995;16(6):270.
[22]Ling Y,Morgan K,Kalsheker N.Amyloid precursor protein(APP)and the biology of proteolytic processing:releveance to Alzheimer's disease[J].Int J Biochem Cell Biol,2003;35(II):1505.
[23]PADovani A,Pastorino L,Borroni B,et al.Amyloid precursor protein in platelets:a peripheral marker for the diagnosis of sporADic AD[J].Neurolo,2001;57(12):2243.
[24]Baskin F,Rosenberg RN,Fang X,et al.Correlation of statin-increased platelet APP ratios and reduced blood lipids in AD patients[J].Neurology,2003;60(12):60.
[25]Assini A,Cammarata S,Vitali A,et al.Plasma levels of amyloid [beta]-protein42 are increased in women with mild cognitive impairment[J].Neurology,2004;63(5):828.
[26]Zoe A,John AL,Linda HY,et al.Serum creatinine level correlate with plasma amyloid β protein[J].Alzheimer Disease Associated Disorders,2002;16(2):187.
[27]MichaelL.Increased homocysteine and decreased ADenosine formation in Alzheimer's disease[J].Neurol Res,2004;26(5):554.
[28]Hull M,Pasinetti GM,Aisen PS.Elevated plasma neopterin levels in Alzheimer disease[J].Alzheimer Disease Associated Disorders,2000:14(4):228.
[29]Schipper H,Chertkow H,Mehindate K,et al.Evaluation of heme oxygenase-1as a systemic biological marker of sporADic AD[J].Neurology,2000;54(6):1297.
[30]Gattaz WF,Forlenza or,Talib LL,et al.Platelet phospholipase A(2) activity in Alzheimer' s disease and mild cognitive impairment[J].J Neural Transmission,2004;111(5):591.
[31]Lorenzl S,Albers DS,Relkin N,et al.Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer' s disease[J].Neurochem Int,2003:43(3):191.
[32]马路,张吉强,姚清.雌激素合成酶与雌激素受体在神经干细胞及其分化后细胞内的表达[J].重庆医学,2005;34(4):560.
[33]Zhang S,Huang Y,Zhu YC,et al.Estrogen stimulates release of secreted amyloid precursor protein from primary rat cortical neurons via protein kinase C pathway[J].Acta Pharmacol Sin,2005;26(2):171.
[34]Rainer T,Dip 1P,Dirk A.Serum nerve growth factor concentration and its role in the preclinical stage of dementia[J].Am J Psychiatyy,2002;159(7):1227.
[35]Grammas P,Ovase R.Cerebrovascular transforming growth factor-betac ontributes to inflammation in th Alzheimer' s disease brain[J].Am J Pathol,2002:160(5):1583.
[36]秦新月,余刚,董维伟,等.TNF2A对离体培养的少突胶质细胞和髓鞘生长的影响[J].重庆医学,2004;33(7):1061.
[37]Molina M,Robert AF,Krnneth H.Oxidative stress and neuroinflammation in Alzheimer' s diseaseand amyotrophiclateral sclerosis:common links and potential therapentic targets[J].J Alzheimer' s Dis,2004;6(2):147.
[38]Quintanilla RA,Orellana DI,Gonzalez-Billault C,et al.Interleukin-6induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p3 5pathway[J].Exp Cel IRes,2004;295(1):245.
[39]Bagli M,Papassotiropoulos A,Hampel H.Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer' s disease Results of a pilot study[J].Eur Arc Psychiatry Clin Neurosci,2003;253(1):44.
[40]董会卿,颜振瀛,李坤成,等.MRI线性测量局部脑萎缩对早期阿尔兹海默病的诊断意义.中华神经科杂志,1998;31:92-94.
[41]Knopman DS,DeKosky ST,Cummings JL,et al.Practice parameter:Diagnosis of dementia(an evidence-based review)Report of the Qualit Standards Subcommittee of the American AcADemy of Neurology.Neurology,2001; 56:1143-1153.
[42]Villareal DT,Morris JC.The Diagnosis of Alzheimer' s Disease.Alzheimer' s Disease Review,1998:3:142-152.
[43]Anthony D,Wagner AD.Early detection of Alzheimer' s disease:An MRI marker for people at risk.Nature Neuroscience,2000:3:973-974.
[44]Herholz K.PET studies in dementia.Ann Nucl Med,2003:17:79-89.
[45]李岳峙,王明时.脑电在老年性痴呆诊断中的应用.国外医学生物医学工程分册,1998:21(1):8-11.
[46]Goodin D,Squires K,Starr A.A long latency event-related components of the auditory evoked potential in dementia.Brain,1978;101:635-648.
[47]Goodin D,Starr A,Chippendale T,et al.Sequential changes in the P300component of the auditory evoked potential in confusional states and dementing illness.Neurology,1983;33:1215-1218.
[48]Michikawa M.The role of cholesterol in pathogenesis ofAlzheimer' s disease dual me tabolic in te raction between amyloid betal protein and cholescrol[J].Mol Neurobiol,2003;27(1):1-12.
[49]Caballero,J NabataM.Do statins slow down Alzheimer' s diseases[J].Clin Pharm Ther,2004;29(3):209-213.
[50]Mackenzie IR,Moons DG.Nonsteroid anti-inflam matory drug use and Alzheimer type pathology in aging[J].Neurology,2002:16(1):39-41.
[51]Jay PR,Loren GI.Focus on Donepezil A reverstale acctyleholineste rase inbibitor for the neament of Alzheimers' s disease[J].Medical Progress SEA,2003:25(1):42.
[52]张振馨,赵洁皓,黄觉斌,等.老年性痴呆(AD)的药物治疗[M].北京:科学技术文献出版社,2000,54-80.
[53]Poirier J,Delisle MC,Quirion R,et al.Apolipoprote in E4 allele as a predictor of cholinergic deficits and treatment outeomc in Alzheimer' s diease[J],Proc Natl AcAD Sci USA,2002:92(2):260-284.
[54]Cummings JI,Cyrus PA,Bieber E,et al.Metrifonate treatment of the cognitive defic of Alzheiners' s disease[J].Neurology,2002;50(10):1214-1221.
[55]花戎.增智灵对老年痴呆长谷川量表与实验鼠的影响.辽宁中医杂志,2003;30(6):510.
[56]周荣根.白虎汤加减治疗老年性痴呆23例.陕西中医,2003;23(8):700.
[57]康雁,易志宏,王丽.自拟扶智汤治疗老年痴呆症23例疗效观察.中医药学报, 2000:(2):10.
[58]黄冬度.中药治疗老年痴呆49例.实用中医药杂志,2003;19(9):465.
[59]李琼锋,郭翔兵.七生力片治疗老年性痴呆30例.福建中医药,2003;34(1):14.
[60]王娅玲.辨证治疗老年性痴呆22例小结.浙江中西医结合杂志,2000;10(6):349.
[61]王建明.七福饮加味治疗老年性痴呆32例.辽宁中医杂志,2002;29(1):43.
[62]卢绍城.老年性痴呆诊治心法.辽宁中医学院学报,2002;4(1):8.
[63]杨湘潭.针灸醒脑开窍法为主治疗老年性痴呆26例[J].中国针灸,1996;16,(11):3.
[64]唐勇,余曙光,蓝群.针刺对老年痴呆认知功能及自由基的影响.安徽中医临床杂志,2000;12(6):508-509.
[65]唐勇,余曙光,陈瑾.针刺对老年性痴呆认知功能及AchE的影响.上海针灸杂志,2001:20(3):6-7.
[66]杨子江,李淑娥.多针透刺法治疗老年性痴呆.针灸临床杂志,1995;11(3):34.
[67]沈卫东.老年痴呆针灸治疗的临床初步研究.上海针灸杂志,1996;15(5):5.
[68]叶衡.四神聪对锋刺治疗老年性痴呆.上海针灸杂志,1993;12(11):520.
[69]赖新生,余瑾,庄礼兴.针刺治疗老年性血管性痴呆的疗效观察.中国针灸,1997:17(4):201.
[70]贺丹,李瑞利,李风鸾.脑复活因子穴位注射疗法治疗阿尔茨海默病疗效观察.脑与神经疾病杂志,2000;8(2):109-111.
[71]董俊峰.穴位注射疗法治疗老年性痴呆症86例.上海针灸杂志,1997;16(3):9.
[72]董宇翔,富琦,李晓春.针刺配合脑活素穴位注射治疗老年性痴呆症.中风与神经疾病杂志,1997;14(4):242.
[73]杨树成.水针治疗老年性痴呆症26例.浙江中医杂志,1995;30(8):357.
[74]穆艳云,李忠仁.针药结合治疗阿尔茨海默病临床研究.上海针灸杂志,2001;20(3):3-5.
[75]李小衡,刘本立.针灸结合中药治疗老年性痴呆病60例.湖南中医药导报,1998;4(12):18-19.
[76]梁忠,吴强,胡兰.针刺中药合用治疗老年性痴呆11例的临床总结.中国针灸,1998:18(12):712-714.
[77]欧阳颀,李忠仁,穆艳云,等.电针合并奋乃静治疗阿尔茨海默病精神症状的 临床观察.上海针灸杂志,2000;19(6):16-17.
[78]侯安乐,卜渊.针刺药氧治疗老年期痴呆32例临床研究.中国针灸,2000;20(7):397.
[79]车戬,许益强.针药并举治疗老年痴呆症25例.辽宁中医杂志,1997;24(8):317.
[80]罗玉风,盛艳萍,王伟桥.针药并治老年痴呆30例疗效观察.针灸临床杂志,1995:11(1):15.
[81]孙长旺.针刺四神穴为主治疗老年痴呆症经验.天津中医,1997;14(2):79-80.
[82]韦思泉.针药并用治疗老年性痴呆25例.黑龙江中医药,1999;(3):57.
[83]董洪涛,白英.针刺疗法对老年性痴呆患者MMSE量表得分的影响.中医外治杂志,2002:11(3):6-7.
[84]伦新,杨文辉.“CT定位围针法”治疗痴呆的临床观察.上海针灸杂志,2000;19(1):20.
[85]尚颖,丁宁.针刺治疗老年性痴呆24例TCD观察.中国中医药科技,2003;10(4):229.
[86]姜国华,徐强,张洋.针刺对老年性痴呆神经行为学影响的临床研究.针灸临床杂志,2004;20(4):1-3.
[87]罗玳红,赖新生,唐纯志.电针治疗老年性痴呆大鼠血清β淀粉样蛋白及生长因子水平的影响.中国中医药信息杂志,2003;10:10.
[88]Joosten E,Lesaffre E,Riezler R,et al.Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in early patients with Alzheimer' s disease[J].Gerontol A Biol Sci Med Sci,1997:52:M57-59.
[89]柯晓燕,张颖冬,沈伟,等.老年性痴呆52例血浆同型半胱氨酸水平的研究[J].南京医科大学学报(自然科学版),2002;22(5):386.
[90]李方明,彭海.阿尔茨海默病与维生素B12及同型半胱氨酸的相关性[J].中国临床康复,2004;28(8):6210.
[91]张诚,吴瑞枝,陈芷茹.43例老年性痴呆的临床与分析[J].临床脑电学杂志,1995:4(3):65.
[92]陆小莲,杨红,周谷兰,等.老年性痴呆的脑电图观察.河北医药,2005;11(10):930.
[93]戴新民,张尊祥,等.楮实治疗老年性痴呆的临床观察.解放军保健医学杂志,1999;4:22.
[94]唐省三.“针必取三里,灸必加关元”浅见[J].山东中医杂志,2002;21(4):245-246.